Skip to main content
. 2021 Apr 13;39(5):868–875. doi: 10.1007/s00774-021-01226-1

Fig. 2.

Fig. 2

Comparison of longitudinal changes in a serum P1NP and b serum TRACP-5b levels at 3-, 6-, and 12-month post-administration. Data show mean ± standard error of the mean, *P < 0.05: Romosozumab vs. Denosumab, †P < 0.05: non-bisphosphonate vs. bisphosphonate. #P < 0.05, interaction. BP bisphosphonates, P1NP total type 1 procollagen-N-propeptide, TRACP-5b tartrate-resistant acid phosphatase 5b